BDMD vs RMTI

The Advanced Deterministic Scorecard reveals a critically weak financial profile with a Piotroski F-Score of just 3/9, indicating poor financial health. Despite a seemingly reasonable Price/Book of 0.77 and a strong Gross Margin of 86.94%, the company is deeply unprofitable with negative operating and net margins, collapsing revenue, and no analyst coverage. The complete absence of Altman Z-Score and intrinsic value calculations, combined with a 5-year return of -89.3%, signals severe distress. Technical indicators and insider sentiment are also weak, reinforcing a high-risk outlook.

RMTI exhibits severe financial distress as evidenced by a Piotroski F-Score of 1/9, indicating critical weakness across profitability and operational efficiency. Despite a strong current ratio of 3.98 and low debt-to-equity, the company is suffering from a significant revenue contraction of -25.60% YoY and consistent earnings misses (0/4 beats in the last year). The disconnect between the analyst target price of $3.00 and the actual fundamental decay, coupled with bearish insider selling, suggests a high-risk speculative profile.